Skip to main content
Premium Trial:

Request an Annual Quote

David Atkins

David Atkins has been named CEO of Congenica, a Cambridge, England-based maker of clinical genomics interpretation software. Atkins will lead Congenica as it looks to expand to the US and Asia, the company said. He previously served as CEO of Synevo, a chain of clinical diagnostic laboratories in Germany and Eastern Europe. With the hiring of Atkins, interim CEO Nick Lench resumes his full-time duties as chief operating officer. Cofounder and former CEO Tom Weaver remains on the Congenica board.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.